# General Oncology, Inc. — Form D/A

General Oncology, Inc. of Newton, MA, a company, filed a Form D amendment with the SEC on 2022-12-22. The offering totals $7.5M, of which $3.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-12-22
- Form: D/A
- Accession: 0001658021-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $3.2M
- Remaining: $4.3M
- Investors: 31
- Date of first sale: 2019-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-343809

## Issuer

- Name: General Oncology, Inc.
- CIK: 0001658021
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 57 Chapel Street, Third Floor 57 Chapel Street, Third Floor, Newton, MA, 02458
- Phone: 617-468-4646

## Officers, directors & promoters (18)

| Name | Role | Location |
| --- | --- | --- |
| Michael J Petit | Director | Brookline, MA |
| Arnold Aaron Glazier | Director | Brookline, MA |
| Arnold Aaron Glazier | Executive Officer | Brookline, MA |
| Abid J Ansari | Executive Officer | Brookline, MA |
| Barry J Seeman | Director | Brookline, MA |
| Jeffrey Aaron Glazier | Director | Newton, MA |
| Jeffrey Aaron Glazier | Executive Officer | Newton, MA |
| Jeffrey Aaron Glazier | Related Person | Newton, MA |
| Gregg Goldstein | Director | Brookline, MA |
| Gregg Goldstein | Executive Officer | Brookline, MA |
| Arnold Glazier | Director | Newton, MA |
| Arnold Glazier | Executive Officer | Newton, MA |
| Arnold Glazier | Related Person | Newton, MA |
| Michael D Sigman | Director | Brookline, MA |
| Abid Ansari | Related Person | Newton, MA |
| Henry Esber | Director | San Diego, CA |
| Michael J. Petit | Related Person | Newton, MA |
| Barry Seeman | Related Person | Newton, MA |

## Other filings by this issuer (11)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-04-23](https://search.stillhousedata.com/formd/0001658021-26-000006) | D | $4.8M | $4.8M |
| [2025-07-02](https://search.stillhousedata.com/formd/0001658021-25-000002) | D/A | $17.3M | $10.9M |
| [2024-07-02](https://search.stillhousedata.com/formd/0001658021-24-000001) | D/A | $11.3M | $7.2M |
| [2023-12-21](https://search.stillhousedata.com/formd/0001658021-23-000001) | D/A | $7.5M | $6.0M |
| [2022-11-10](https://search.stillhousedata.com/formd/0001658021-22-000001) | D/A | $3.8M | $3.2M |
| [2021-11-10](https://search.stillhousedata.com/formd/0001658021-21-000002) | D/A | $3.8M | $2.3M |
| [2020-12-23](https://search.stillhousedata.com/formd/0001658021-20-000002) | D/A | $2.5M | $1.4M |
| [2020-07-14](https://search.stillhousedata.com/formd/0001658021-20-000001) | D/A | $1.3M | $730K |
| [2019-07-09](https://search.stillhousedata.com/formd/0001658021-19-000001) | D | $1.3M | $445K |
| [2017-09-05](https://search.stillhousedata.com/formd/0001658021-17-000001) | D/A | $46.9M | $34.8M |
| [2015-11-16](https://search.stillhousedata.com/formd/0001658021-15-000001) | D | $46.9M | $31.3M |

## More

- [CIK 1658021 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1658021&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001658021-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.